The terminal sterilization market is estimated to secure a valuation of US$11.5 Billion in 2023 and is estimated to rise to US$ 26 Billion by 2033. The market is anticipated to grow at a CAGR of 8.5% during the forecast period. The factors accelerating the demand for terminal sterilization are as follows-
The terminal sterilization includes Ethelyne oxide sterilization, irradiation, moist heat sterilization, and vaporized hydron peroxide sterilization. The growing awareness about the diseases and infections caused due to nonsterile products will fuel the growth of the terminal sterilization market
The increased application of terminal sterilization in hospitals, pharmaceutical companies, biopharmaceutical companies, medical device companies, and diagnostic labs is expected to provide an opportunity for market growth during the forecast period.
The increased demand for reusable medical devices is likely to drive the growth of the market. On the basis of product segment ethylene oxide segment accounts for the highest share of the terminal sterilization market.
North America accounts for the highest share of the terminal sterilization market owing to the increasing number of surgeries performed along with the increasing prevalence of hospitals acquired infections in the region. Europe accounts for the second highest share of the market owing to the increased demand for non-disposable surgical instruments in the region.
The terminal sterilization market in the Asia Pacific is expected to grow at a steady pace during the forecast period due to the improved healthcare infrastructure and massive investment by the government.
Some of the leading players operating in the terminal sterilization market include Johnson & Johnson, DuPont, Steris plc, Getinge Group, Advanced sterilization Product services Inc, 3M, Belimed, Cantel Medical, Matachana Group, Sterigenics International LLC, Olympus Corp, TSO3, Celitron, MMM Group, Fedigari Group among others.
The global market for terminal sterilization is fragmented with the presence of many small and large market players. The market players operating in the terminal sterilization market are adopting different strategies for market expansion. The key players operating in the terminal sterilization market are expanding their manufacturing facilities and also the players are investing heavily in R&D activities to develop and launch cost-effective products
For instance, in September 2021- nelson Labs and Sterigenics Germany GmBH announced today the opening of a newly expanded center of excellence for microbiological laboratory testing as well as increasing sterilization capacity in the Wiesbaden, Germany Facility.
The demand for terminal sterilization is expected to continue to grow during the forecast period. The launch of innovative products increased advancement in the sterilization process and increasing investment in research & development by market players are anticipated to boost the demand for terminal sterilization products. This led to market growth.
For instance, founded in 2004- Sterilucent produces a sterilant PSD-85 Hydrogen peroxide sterilizer which is designed to resist damage during travel and be optional. The company claims that the PSD-85 system is a low-temperature sterilization technology that offers expanded material compatibility, particularly for temperature and moisture-sensitive items that can’t be steam sterilized.
| Data Point | Key statistics |
|---|---|
| Expected Market value in 2023 | US$ 11.5 Billion |
| Projected Market Value in 2033 | US$ 26 Billion |
| Growth Rate (2023 to 2033) | CAGR of 8.5% |
Significant Demand for terminal sterilization due to pandemic situation, with optimistic growth outlook in the long-run. Rising demand from the medical device industry will increase the opportunities in near future, however, the service of terminal sterilization in the pharmaceutical sector will provide momentum.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Growing demand for terminal sterilization for drug products amongst end-user continues to drive demand for terminal sterilization. Moreover, the launch of innovative product and technological advancements in the sterilization process will fuel the growth of the terminal sterilization market.
Terminal sterilization market has to gain attention over the past few years due to rising awareness about diseases and infection caused due to non-sterile environment. Besides, growing investment in healthcare infrastructure, research and focused on public health adaption of terminal sterilization is increasing significantly.
Furthermore, the rising prevalence of infectious disease, cancer, diabetes, autoimmune diseases anticipated accelerating the demand of for terminal sterilization services. This is especially true with increasing incidence of contagious disease such as bacterial and viral infections will increasing the demand for terminal sterilization.
The USA remains one of the largest markets for terminal sterilization globally. FMI has projected the USA will hold significant markets share throughout the course of the forecast period. Key pharmaceutical companies have announced their intentions to invest in manufacturing facilities in the USA for instance, in 2018, Eli Lilly invested US$ 72.0 million for an insulin manufacturing project.
Hence, demand for the terminal sterilization market will boost during the assessment period 2021 to 2031.
Demand for terminal sterilization in the USA and Canada will be increase due to the increasing number of surgeries and high prevalence of hospital-acquired infections. For instance, Commercial aerospace will account for low demand for terminal sterilization till 2024, according to Healthcare Information and Management Systems Society, in the USA every day, 1 out of 25 patients are infected by hospital-acquired infection.
In addition, USA and Canada have a well- precise regulation for terminal sterilization are some other factors fueling the market growth in the country.
Principal Consultant
Terminal sterilization market has gained traction in European countries in recent years due to the adaption of the aseptic environment in healthcare facilities.
Moreover, extended use of the sterilized products for storing and packaging pharmaceutical and food supplies will boost the demand for Terminal sterilization services in the European market. Furthermore, some prominent players in Terminal sterilization services are present in European countries which creates significant revenue growth.
Some of the leading manufacturers and suppliers of terminal sterilization include
Many leading manufacturers and service providers have a strategic acquisition to for strengthening their position in the terminal sterilization market. For instance, in August 2020, Sharp, part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has purchased a minority ownership in Berkshire Sterile Manufacturing (BSM). Terminal sterilization is mostly used for pharmaceutical and medical device sterilization.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Explore Healthcare Insights
View Reports
Terminal sterilization Market
